No Target Data

The consensus price target for CBAN is $N/A, close to the current price of $20.56 (N/A% implied move). Based on 2 analyst estimates, the stock appears fairly valued near current levels.

CBAN has a consensus rating of "Hold" based on 2 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.

With a forward P/E of 10.4535x, CBAN trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $N/A for CBAN, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $33 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CBAN is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CBAN stock forecast based on 2 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $25, with bear/bull scenarios of $16/$33.

Our quantitative valuation model calculates CBAN's fair value at $25 (base case), with a bear case of $16 and bull case of $33. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 40/100.

CBAN trades at a forward P/E ratio of 10.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

CBAN appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CBAN analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $16-$33 range provides an independent fundamental perspective.